other language:
English
Microbial Pathogenicity Mechanisms
Publications
Publications
ORIGINAL PUBLICATIONS & REVIEWS 2013
Borges Pereira Costa AC, Aparecida Pereira A , Freire F, Campos Junqueira J, Cardoso Jorge AO (2013) Methods for obtaining reliable and reproducible results in studies of Candida biofilms formed in vitro. Mycoses, accepted.
Hennicke F, Grumbt M, Lermann U, Ueberschaar N, Palige K, Böttcher B, Jacobsen ID, Staib C, Morschhäuser J, Monod M, Hube B, Hertweck C, Staib P (2013) Factors supporting cysteine tolerance and sulfite production in Candida albicans. Eukaryot Cell, accepted. [PubMed]
Lüttich A, Brunke S, Hube B, Jacobsen ID (2013) Serial passaging of Candida albicans in systemic murine infection suggests that the wild type strain SC5314 is well adapted to the murine kidney. PLoSOne, accepted.
Martin R, Albrecht-Eckardt D, Brunke S, Hube B, Hünniger K, Kurzai O (2013) A core filamentation response network in Candida albicans is restricted to eight genes. PLoS One 8, e58613. [PubMed]
Mayer FL, Wilson D, Hube B (2013) Hsp21 potentiates antifungal drug tolerance in Candida albicans. PloS One, accepted.
Pietrella D, Pandey N, Elena G, Eva P, Perito S, Kasper L, Bistoni F, Cassone A, Hube B, Vecchiarelli A (2012) Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome. Eur J Immunol 7, e52850. [PubMed]
Wagener J, Schneider JJ, Baxmann S, Kalbacher H, Borelli C, Nuding S, Küchler R, Wehkamp J, Kaeser MD, Mailänder-Sanchez D, Braunsdorf C, Hube B, Schild L, Forssmann WG, Korting HC, Liepke C, Schaller M (2013) A peptide derived from the highly conserved protein GAPDH is involved in tissue protection by different antifungal strategies and epithelial immunomodulation. J Invest Dermatol 133, 144-153. [PubMed]
REVIEWS
Brunke S, Hube B (2013) Two unlike cousins: Candida albicans and C. glabrata infection strategies. Cell Microbiol 15, 701-708. [PubMed]
Mayer FL, Wilson D, Hube B (2013) Candida albicans pathogenicity mechanisms. Virulence 4, 119-128. [Abstract] [Full text] [PDF]
Miramón P, Kasper L, Hube B (2013) Thriving within the host: Candida spp. interactions with phagocytic cells. Med Microbiol Immunol, accepted. [PubMed]
Hennicke F, Grumbt M, Lermann U, Ueberschaar N, Palige K, Böttcher B, Jacobsen ID, Staib C, Morschhäuser J, Monod M, Hube B, Hertweck C, Staib P (2013) Factors supporting cysteine tolerance and sulfite production in Candida albicans. Eukaryot Cell, accepted. [PubMed]
Lüttich A, Brunke S, Hube B, Jacobsen ID (2013) Serial passaging of Candida albicans in systemic murine infection suggests that the wild type strain SC5314 is well adapted to the murine kidney. PLoSOne, accepted.
Martin R, Albrecht-Eckardt D, Brunke S, Hube B, Hünniger K, Kurzai O (2013) A core filamentation response network in Candida albicans is restricted to eight genes. PLoS One 8, e58613. [PubMed]
Mayer FL, Wilson D, Hube B (2013) Hsp21 potentiates antifungal drug tolerance in Candida albicans. PloS One, accepted.
Pietrella D, Pandey N, Elena G, Eva P, Perito S, Kasper L, Bistoni F, Cassone A, Hube B, Vecchiarelli A (2012) Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome. Eur J Immunol 7, e52850. [PubMed]
Wagener J, Schneider JJ, Baxmann S, Kalbacher H, Borelli C, Nuding S, Küchler R, Wehkamp J, Kaeser MD, Mailänder-Sanchez D, Braunsdorf C, Hube B, Schild L, Forssmann WG, Korting HC, Liepke C, Schaller M (2013) A peptide derived from the highly conserved protein GAPDH is involved in tissue protection by different antifungal strategies and epithelial immunomodulation. J Invest Dermatol 133, 144-153. [PubMed]
REVIEWS
Brunke S, Hube B (2013) Two unlike cousins: Candida albicans and C. glabrata infection strategies. Cell Microbiol 15, 701-708. [PubMed]
Mayer FL, Wilson D, Hube B (2013) Candida albicans pathogenicity mechanisms. Virulence 4, 119-128. [Abstract] [Full text] [PDF]
Miramón P, Kasper L, Hube B (2013) Thriving within the host: Candida spp. interactions with phagocytic cells. Med Microbiol Immunol, accepted. [PubMed]
Print Page